TPC-144
TPC-144 is a LSD1/KDM1A inhibitor. TPC-144 inhibits LSD1, and leads to a decrease in the protein level of DNMT1, causing low methylation of the LINE-1 element. TPC-144 can also produce a synergistic effect with Decitabine (a DNMT inhibitor), jointly promoting DNA demethylation and thereby inducing differentiation and apoptosis of leukemia cells. TPC-144 has also demonstrated anti-tumor efficacy in acute myeloid leukemia (AML) models. TPC-144 can be used for the study of AML[1][2].
Product Specifications
CAS Number
2098621-17-9
UNSPSC
12352005
Target
Apoptosis; Histone Demethylase
Related Pathways
Apoptosis; Epigenetics
Field of Research
Cancer
Smiles
N[C@H]1C[C@H]2CC[C@@H](C1)N2C(C3=CC(C4=CC=C(C(F)=C4)C#N)=C(C=C3)C5=CC=C(C=C5F)CC(O)(C)C)=O
Molecular Formula
C31H31F2N3O2
Molecular Weight
515.59
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NYX, NT (NYX, CLRP, Nyctalopin) (MaxLight 490)
NYX, NT (NYX, CLRP, Nyctalopin) (MaxLight 490)